Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9444 |
High Similarity |
NPD1653 |
Approved |
0.8367 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8282 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8242 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.816 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8133 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8113 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8082 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8082 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8071 |
Intermediate Similarity |
NPD1091 |
Approved |
0.805 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7875 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7808 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.775 |
Intermediate Similarity |
NPD37 |
Approved |
0.774 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7716 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7711 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7711 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7547 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7532 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7383 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7378 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7358 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7321 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD447 |
Suspended |
0.732 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7289 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7267 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7257 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7257 |
Intermediate Similarity |
NPD8313 |
Approved |
0.725 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7211 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7175 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD919 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7073 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7027 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7025 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7013 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7 |
Intermediate Similarity |
NPD290 |
Approved |
0.6994 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6986 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD5762 |
Approved |
0.6981 |
Remote Similarity |
NPD5763 |
Approved |
0.6978 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD9697 |
Approved |
0.6975 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD7680 |
Approved |
0.6968 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6961 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD1778 |
Approved |
0.6954 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6951 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD7583 |
Approved |
0.6937 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6911 |
Remote Similarity |
NPD7585 |
Approved |
0.6908 |
Remote Similarity |
NPD2797 |
Approved |
0.689 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6875 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6875 |
Remote Similarity |
NPD7843 |
Approved |
0.6855 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6855 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6852 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6849 |
Remote Similarity |
NPD7157 |
Approved |
0.6845 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD8651 |
Approved |
0.6839 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD7095 |
Approved |
0.6835 |
Remote Similarity |
NPD6653 |
Approved |
0.6831 |
Remote Similarity |
NPD2684 |
Approved |
0.6826 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6815 |
Remote Similarity |
NPD4140 |
Approved |
0.6813 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6809 |
Remote Similarity |
NPD3134 |
Approved |
0.6806 |
Remote Similarity |
NPD228 |
Approved |
0.68 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD3268 |
Approved |
0.6792 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD4536 |
Approved |
0.6792 |
Remote Similarity |
NPD4538 |
Approved |
0.6792 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.679 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6786 |
Remote Similarity |
NPD4675 |
Approved |
0.6786 |
Remote Similarity |
NPD4678 |
Approved |
0.6779 |
Remote Similarity |
NPD5691 |
Approved |
0.6774 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6772 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.677 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6763 |
Remote Similarity |
NPD5677 |
Discontinued |
0.676 |
Remote Similarity |
NPD7039 |
Approved |
0.676 |
Remote Similarity |
NPD7038 |
Approved |
0.6759 |
Remote Similarity |
NPD5535 |
Approved |
0.675 |
Remote Similarity |
NPD5588 |
Approved |
0.675 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6744 |
Remote Similarity |
NPD3749 |
Approved |
0.6733 |
Remote Similarity |
NPD4626 |
Approved |
0.673 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.6727 |
Remote Similarity |
NPD5297 |
Approved |
0.6727 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6727 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6727 |
Remote Similarity |
NPD1774 |
Approved |
0.6725 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD2415 |
Discontinued |
0.6724 |
Remote Similarity |
NPD1247 |
Approved |
0.6718 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6718 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6712 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6711 |
Remote Similarity |
NPD9717 |
Approved |
0.6708
|
Remote Similarity |
NPD2935 |
Discontinued |